Valerion Therapeutics

valerion.com

Is a

Company

Organization

Company attributes

Industry

Technology

Engineering

Biomedical engineering

Biotechnology

Therapeutics

Biology

Location

Concord, Massachusetts

Medford, Massachusetts

B2X

D2C

CEO

Deborah Ramsdell

Founder

Dustin Armstrong

AngelList URL

angel.co/valerion-therapeutics

Pitchbook URL

pitchbook.com/profiles.../53985-97

Legal Name

Valerion Therapeutics, LLC

Legal classification

Limited liability company

Number of Employees (Ranges)

11 – 50

Full Address

00 Main Street Suite 110 Concord, MA 01742 United States

Investors

KLP Enterprises

Total Funding Amount (USD)

21,200,000

Latest Funding Round Date

May 30, 2013

Competitors

Audentes Therapeutics

Latest Funding Type

Series A

Patents Assigned (Count)

Wellfound ID

valerion-therapeutics

Country

United States

Other attributes

Company Operating Status

Active

Wikidata ID

Q30286291

Valerion Therapeutics is a biotechnology company that specializes in developing targeted therapies for orphan genetic diseases. The company generates unique product candidates utilizing a proprietary delivery technology platform that takes advantage of tissue targeting via a novel antibody (3E10) with cell-penetrating properties dependent on a tissue-localized membrane transporter (ENT2).

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.